Difference in clinical and angiographic characteristics of very late stent thrombosis between drug-eluting and bare-metal stent implantations

Circulation Journal

Volumn 77, Issue 6, 2013, Pages 1453-1460

  Kubo, Shunsuke ^a   Kadota, Kazushige ^a   Ozaki, Masatomo ^a   Ichinohe, Tahei ^a   Eguchi, Haruki ^a   Miyake, Koshi ^a   Hyodo, Yusuke ^a   Saito, Naoki ^a   Otsuji, Hideaki ^a   Otsuru, Suguru ^a   Hasegawa, Daiji ^a   Shigemoto, Yoshikazu ^a   Habara, Seiji ^a   Tada, Takeshi ^a   Tanaka, Hiroyuki ^a   Fuku, Yasushi ^a   Katoh, Harumi ^a   Yamamoto, Hiroyuki ^a   Fujii, Satoki ^a   Goto, Tsuyoshi ^a   Mitsudo, Kazuaki ^a   more..

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

Antiplatelet therapy; Coronary artery disease; Stent fracture; Very late stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; INSULIN; PACLITAXEL; RAPAMYCIN; TICLOPIDINE; UMIROLIMUS; ZOTAROLIMUS;

AGED; ANGIOGRAPHY; ARTICLE; BARE METAL STENT; CARDIOVASCULAR RISK; DIABETES MELLITUS; DRUG ELUTING STENT; DRUG WITHDRAWAL; DYSLIPIDEMIA; FEMALE; HEART EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; RIGHT CORONARY ARTERY; STENOSIS; STENT THROMBOSIS;

AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION; PLATELET AGGREGATION INHIBITORS; PREVALENCE; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES; THROMBOSIS; TIME FACTORS;

EID: 84878220056     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-1314     Document Type: Article

References (31)

1. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231.
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
3. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007; 356: 1030-1039.
4. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007; 369: 667-678.
5. Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Juni P, Vaina S, et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice: 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol 2008; 52: 1134-1140.
6. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 2009; 119: 987-995.
7. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.
8. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351.
9. Cook S, Ladich E, Nakazawa G, Eshtehardi P, Neidhart M, Vogel R, et al. Correlation of intravascular ultrasound findings with histopatho-logical analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation 2009; 120: 391-399.
10. Miyazaki S, Hiasa Y, Takahashi T, Yano Y, Minami T, Murakami N, et al. In vivo optical coherence tomography of very late drug-eluting stent thrombosis compared with late in-stent restenosis. Circ J 2012; 76: 390-398.
11. Park SJ, Kang SJ, Virmani R, Nakano M, Ueda Y. In-stent neoath-erosclerosis: A fnal common pathway of late stent failure. J Am Coll Cardiol 2012; 59: 2051-2057.
12. Yamaji K, Inoue K, Nakahashi T, Noguchi M, Domei T, Hyodo M, et al. Bare metal stent thrombosis and in-stent neoatherosclerosis. Circ Cardiovasc Interv 2012; 5: 47-54.
13. Lee CW, Kang SJ, Park DW, Lee SH, Kim YH, Kim JJ, et al. Intra-vascular ultrasound fndings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol 2010; 55: 1936-1942.
14. Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, et al. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: Five-year outcome of the j-Cypher Registry. Circulation 2012; 125: 584-591.
15. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011; 57: 1314-1322.
16. Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ, et al. Optical coherence tomographic analysis of in-stent neoatherosclero-sis after drug-eluting stent implantation. Circulation 2011; 123: 2954-2963.
17. Brodie B, Pokharel Y, Fleishman N, Bensimhon A, Kissling G, Hansen C, et al. Very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction: A 15-year single-center experience. JACC Cardiovasc Interv 2011; 4: 30-38.
18. Fernandez-Pereira C, Rodriguez-Granillo G, Rodriguez AE. Late stent thrombosis mimicking focal restenosis after sirolimus stent implantation: Angiographic and intravascular ultrasound appraisal. J Invasive Cardiol 2006; 18: E294-E297.
19. Nayak AK, Kawamura A, Nesto RW, Davis G, Jarbeau J, Pyne CT, et al. Myocardial infarction as a presentation of clinical in-stent re-stenosis. Circ J 2006; 70: 1026-1029.
20. Kimura T, Morimoto T, Kozuma K, Honda Y, Kume T, Aizawa T, et al. Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART). Circulation 2010; 122: 52-61.
21. Tokushige A, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, et al. Incidence and outcome of surgical procedures after coronary bare-metal and drug-eluting stent implantation: A report from the CREDO-Kyoto PCI/CABG registry cohort-2. Circ Cardio-vasc Interv 2012; 5: 237-246.
22. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Non-cardiac Surgery): Developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116: e418-e499.
23. Ito T, Terashima M, Kaneda H, Nasu K, Kinoshita Y, Habara M, et al. Very late sirolimus-eluting stent thrombosis due to stent fracture and late-acquired incomplete stent apposition detected on multislice computed tomography. Circ J 2011; 75: 2716-2717.
24. Lee SW, Tam FC, Chan KK. Very late stent thrombosis due to DES fracture: Description of a case and review of potential causes. Catheter Cardiovasc Interv 2011; 78: 1101-1105.
25. Canan T, Lee MS. Drug-eluting stent fracture: Incidence, contributing factors, and clinical implications. Catheter Cardiovasc Interv 2010; 75: 237-245.
26. Umeda H, Kawai T, Misumida N, Ota T, Hayashi K, Iwase M, et al. Impact of sirolimus-eluting stent fracture on 4-year clinical outcomes. Circ Cardiovasc Interv 2011; 4: 349-354.
27. Ino Y, Toyoda Y, Tanaka A, Ishii S, Kusuyama Y, Kubo T, et al. Predictors and prognosis of stent fracture after sirolimus-eluting stent implantation. Circ J 2009; 73: 2036-2041.
28. Nakazawa G, Finn AV, Vorpahl M, Ladich ER, Kolodgie FD, Virmani R. Coronary responses and differential mechanisms of late stent thrombosis attributed to frst-generation sirolimus- and paclitaxel-eluting stents. J Am Coll Cardiol 2011; 57: 390-398.
29. Doi H, Maehara A, Mintz GS, Tsujita K, Kubo T, Castellanos C, et al. Classifcation and potential mechanisms of intravascular ultrasound patterns of stent fracture. Am J Cardiol 2009; 103: 818-823.
30. Ino Y, Toyoda Y, Tanaka A, Ishii S, Kusuyama Y, Kubo T, et al. Serial angiographic fndings and prognosis of stent fracture site without early restenosis after sirolimus-eluting stent implantation. Am Heart J 2010; 160: 775.e1-e9.
31. Davlouros PA, Chefneux C, Xanthopoulou I, Papathanasiou M, Zaharioglou E, Tsigkas G, et al. Flat panel digital detector cinefuo-roscopy late following SES or BMS implantation for detection of coronary stent fracture in asymptomatic patients. Int J Cardiol 2012; 156: 277-282.